Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells
Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells. Shamri R, Dubois G, Erpenbeck VJ, Mankuta D, Sandham DA, Levi-Schaffer F. Clin Exp Allergy. 2019 Feb;49(2):255-257. doi: 10.1111/cea.13304. Epub 2018 Nov 25. PMID: 30379368
Our society needs to renew part of its Council for the next mandate During the general assembly of our society that will take place during the
Agenda June 18th, 2024 10:00-11:30 am EAACI symposium title: Immune responses at the barrier sites through the lenses of new nomenclature of allergy and clinical immunology Symposium Objective:
Summary Autoimmunity is the break of tolerance to self-antigens that leads to organ-specific or systemic diseases often characterized by the presence of pathogenic autoreactive antibodies (AAb)